These data indicate that even in healthy controls, which display a noticeably lower frequency of PD-1+ cells compared to SLE patients, the expression of PD-1 on CD4+ CD45RA− T cells is a sensitive marker of immune activation and putative ongoing inflammation. This evidence concerns the gene PDCD1 and systemic lupus erythematosus.